A Single-Blinded, Randomized, Controlled, Phase 2 Pilot Study to Evaluate the Safety and Efficacy of Denosumab Compared to Zoledronic Acid for the Treatment of Osteoporosis in Children
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 24 Nov 2016 Status changed from not yet recruiting to recruiting.
- 26 Jul 2016 Planned initiation date changed from 1 Mar 2016 to 1 Oct 2016.
- 21 Dec 2015 New trial record